Dare Bioscience Inc
(DARE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,666 | -11,503 | -2,372 | -742 | -244 |
| Depreciation Amortization | 5,188 | 7,491 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -40 | 218 | N/A | N/A | N/A |
| Other Working Capital | 348 | 1,140 | 469 | 582 | 193 |
| Other Operating Activity | 52 | 114 | 324 | 0 | 0 |
| Operating Cash Flow | $-2,119 | $-2,540 | $-1,579 | $-160 | $-51 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | 9,918 | 9,918 | N/A | N/A |
| Investing Cash Flow | $N/A | $9,918 | $9,918 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 155 | 155 | 155 | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 100 |
| Common Stock Issued | 10,198 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $10,198 | $155 | $155 | $155 | $100 |
| Exchange Rate Effect | -14 | -18 | -10 | N/A | N/A |
| Beginning Cash Position | 7,560 | 45 | 45 | 45 | 45 |
| End Cash Position | 15,625 | 7,560 | 8,529 | 39 | 94 |
| Net Cash Flow | $8,065 | $7,515 | $8,485 | $-5 | $49 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,119 | -2,540 | -1,579 | -160 | -51 |
| Free Cash Flow | -2,119 | -2,540 | -1,579 | -160 | -51 |